KZR: Kezar Life Sciences Inc. Bozor kapitallashuvining balans qiymatiga nisbati
GURU.Markets platformasidagi ushbu jadval Kezar Life Sciences (KZR) kompaniyasining narxlardagi o'zgarishini ko'rsatadi, uning faoliyati kimyoviy chiqindilarni yo'q qilish standartlariga rioya qilishga asoslangan. Joriy ko'rsatkich 0.83. Kezar Life Sciences (KZR) patent himoyasi va FDA qarorlariga tayanib, og'ir patologiyalarga qarshi kurashish uchun kichik molekulalarni ishlab chiqishga qaratilgan. Biznes modeli ishlab chiqarish va sinov uchun tashqi pudratchilarni jalb qilishga asoslangan.
%20Balans%20qiymatiga%20nisbatan%20bozor%20qiymati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_KZR_-_Kezar-Life-Sciences_-_Market-Value-to-Book-Value "Kezar Life Sciences, Inc - KZR Bozor kapitallashuvining balans qiymatiga nisbati (davr: 04.07.2022 - 23.05.2026) | 👁️GURU.Markets👁️")
Kezar Life Sciences Inc. (KZR) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning xususiy kapitalga nisbati Kezar Life Sciences|KZR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Kezar Life Sciences, Inc|KZR - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Kezar Life Sciences, Inc|KZR - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzlari Kezar Life Sciences|Tezkor likvidlik kezarlifesciences.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning dastlabki tahlili:Kezar Life Sciences, KZR
Buxgalteriya qiymatiga nisbatan narx (P/BV) koeffitsiyenti kompaniyaning sof aktivlariga nisbatan bozor baholovishining premiumi yoki diskontini o'lchaydi. Investorlar ushbu koeffitsiyentdan xavfsizlik zaxirasini aniqlash va resurslarni almashtirish xarajatlarining haddan tashqari yuqori baholanganligini tahlil qilish uchun foydalanadilar. Kezar Life Sciences (KZR) uchun tarixiy P/BV koeffitsiyenti bozorning kompaniya intellektual mulki qiymatini qanday talqin qilishini aks ettiradi. Autoimmun kasalliklar terapiyasi ishlab chiquvchilari uchun ushbu metrika kapital boshqaruvining samaradorligini tasdiqlaydi. Intizomli boshqaruv aktivlarni optimallashtirish imkonini beradi va bozor premiumlari yuqori bo'lgan davrlarda qiymatning keskin pasayishi xavfini minimallashtiradi.
Kezar Life Sciences kimlar bilan raqobatlashadi
argenx SE (ARGX) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi BNTX (biontech.de)|ABVX (abivax.com) - Bozor kapitallashuvining balans qiymatiga nisbati|ADMA: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|Bozor kapitallashuvining balans qiymatiga nisbati Immunovant Therapeutics (IMVT)|Bozor qiymatining balans qiymatiga nisbati Kiniksa Pharmaceuticals KNSA|Balans qiymatiga nisbatan bozor qiymati GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Celldex Therapeutics Inc (CLDX) - Kapitallashuvning sof aktivlarga nisbati|AUPH: Bozor kapitallashuvining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati VERA|DNTH: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati PHVS|Balans qiymatiga nisbatan bozor kapitallashuvi AbCellera Biologics|Bozor qiymatining balans qiymatiga nisbati Tourmaline Corp TRML|PGEN - Kapitallashuvning sof aktivlarga nisbati|PHAR - Bozor qiymatining balans qiymatiga nisbati|nektar.com (NKTR) - Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Kapitallashuvning sof aktivlarga nisbati|Zenas Bio (ZBIO) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Immunome Corp|Kapitallashuvning balans qiymatiga nisbati GOSS (Gossamer Bio Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati KALV|SEPN - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Pieris Pharmaceuticals, Inc. PVLA|Bozor kapitallashuvining balans qiymatiga nisbati Savara Inc SVRA|Rigel Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti AnaptysBio Inc.|ATXS (Astria Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ENGN (engene.com)|RAPT (RAPT Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Aerovate|Bozor qiymatining balans qiymatiga nisbati Aclaris (ACRS)|KYTX (Kyverna Therapeutics, Inc) - Balans qiymatiga nisbatan bozor qiymati|Tiziana Life Sciences - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati CABA|VTYX - Bozor qiymatining balans qiymatiga nisbati|THTX: Bozor qiymatining balans qiymatiga nisbati|AVTX: Bozor kapitallashuvining balans qiymatiga nisbati|ELDN - Balans qiymatiga nisbatan bozor kapitallashuvi|AGEN (Agenus) - Bozor kapitallashuvining balans qiymatiga nisbati|climbbio.com - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ZURA|ATYR - Bozor qiymatining balans qiymatiga koeffitsiyenti|Adagene Inc. - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati IMA|STTK - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Equillium, Inc. EQ|CNTB: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Immunic|ATRA (Atara Biotherapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|InflaRx GmbH (IFRX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati XFOR|ACET - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Celularity CELU|INMB: Kapitallashuvning balans qiymatiga nisbati|Barinthus Bio - Bozor kapitallashuvining balans qiymatiga nisbati|SAB Biotherapeutics Inc (SABS) - Kapitallashuvning sof aktivlarga nisbati|AKTX: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Enlivex Therapeutics Ltd. (ENLV)|Bozor qiymatining balans qiymatiga nisbati Q32 Bio Inc|GeoVax Labs (GOVX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Edesa (EDSA)|Bozor kapitallashuvining balans qiymatiga nisbati iBio Corporation (IBIO)|Carisma Therapeutics Inc. - Kapitallashuvning sof aktivlarga nisbati|XTLB (xtlbio.com) - Sof aktivlarga nisbatan bozor kapitallashuvi|BOLT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HCWB (HCW Biologics Inc.)|aptevotherapeutics.com (APVO) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi AIM (aimimmuno.com)|ADTX (Aditxt Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|GRI: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati XRTX|Bozor kapitallashuvining balans qiymatiga nisbati Vyome Holdings Inc. (HIND)|Bozor qiymatining balans qiymatiga nisbati Revelation Bio REVB|Balans qiymatiga nisbatan bozor qiymati INDP|SCNI - Bozor qiymatining balans qiymatiga nisbati|CalciMedica, Inc. (CALI) - Kapitallashuvning sof aktivlarga nisbati|AFMD: Bozor kapitallashuvining balans qiymatiga nisbati|Allakos (ALLK) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati HOOK|IGMS: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|Balans qiymatiga nisbatan bozor kapitallashuvi oceanbiomedical.com|Bozor qiymatining balans qiymatiga nisbati TC BioPharm TCBP|THRD - Kapitallashuvning sof aktivlarga nisbati